← Leaderboards
Vaiva D Vezys
University Of Minnesota
$4,234,816
Attributed
$5,295,060
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,295,060 · 5
By mechanism
DP2$2,265,000 · 1
R01$2,120,489 · 1
R21$429,202 · 1
R56$408,685 · 1
F32$71,684 · 1
Top collaborators
- Pamela J Skinner3 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Pamela J Skinner$13,080,684
- Branden S Moriarity$9,306,595
- Mary B. Kroetz$98,932
- Michael Tsai$21,953,199
- Shalom Michaeli$6,911,932
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionTissuesT-LymphocyteCellsT Cell ResponseAnimalsPhenotypeSourceNonhuman PrimateNovel TherapeuticsLocationAnti-Retroviral AgentsMacaca MulattaViral Load ResultHiv InfectionsImmunotherapyViralLymphoid TissueAntigensIntestinesImmuneLymph NodesCd8-Positive T-LymphocytesImmunity
Grant awards (9)
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV$702,446
R01 · FY2025 · DK
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV$674,347
R01 · FY2024 · DK
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV$743,696
R01 · FY2023 · DK
Mechanisms of reduced T cell autoimmunity with immune experience$408,685
R56 · FY2022 · AI · contact PI
Therapeutic vaccination targeting SIV viral reservoirs$189,009
R21 · FY2015 · AI · contact PI
Therapeutic vaccination targeting SIV viral reservoirs$240,193
R21 · FY2014 · AI · contact PI
Understanding the Persistence of Immune-mediated Chronic Diseases$2,265,000
DP2 · FY2009 · OD · contact PI
Immunity to Virus-induced Tumors$28,708
F32 · FY2005 · CA
Immunity to Virus-induced Tumors$42,976
F32 · FY2004 · CA